Pharmacokinetics of once-daily darunavir/ ritonavir with and without etravirine in human immunodeficiency virus-infected children, adolescents, and young adults

• Main Authors: Larson K., Cressey T., Yogev R., Wiznia A., Hazra R., Jean-Philippe P., Graham B., Gonzalez A., Britto P., Carey V., Acosta E.
• Format: Journal
• Published: 2017
• Online Access: https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85006200833&origin=inward; http://cmuir.cmu.ac.th/jspui/handle/6653943832/41804
• Institution: Chiang Mai University

© The Author 2015. Limited data are available for once-daily (QD) darunavir (DRV)/ritonavir (r) in the pediatric population. Coadministration of etravirine (ETR) may alter the pharmacokinetics (PK) of DRV. We evaluated the PK interactions between DRV/r (QD) and ETR QD or twice-daily (BID) in childre...